ANTIDOTE THERAPEUTICS INC has a total of 16 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are REGENESANCE B V, PECHER GABRIELE and EPIMMUNE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Australia | 2 | |
#3 | Brazil | 2 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | United States | 2 | |
#7 | China | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Kalnik Matthew W | 13 |
#2 | Thisted Thomas | 13 |
#3 | Reed Charles C | 8 |
#4 | Stone Everett | 7 |
#5 | Rodnick-Smith Max | 6 |
#6 | Lesage Mark G | 3 |
#7 | Beltraminelli Nicola | 3 |
#8 | Matthew W Kalnik | 3 |
#9 | Pentel Paul | 3 |
#10 | Fuller Steve | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020027970A1 | Novel nicotine degrading enzyme variants | |
WO2019236665A1 | Methods for improving circulation and treating cardiovascular disease | |
AU2018215456A1 | Novel nicotine degrading enzyme variants |